Akeso, Inc. (9926.HK) stock analysis
In our weekly check, Akeso, Inc. is graded D (A to F). Of 22 checks on debt, profit, cash flow and trend: 11 pass, warnings: 1, red flags: 10.
About Akeso, Inc.
Akeso, Inc. is a Healthcare company (Biotechnology) based in China, listed on HKSE as 9926.HK.
What our checks show for 9926.HK
Red flags
- Operating profit does not cover the interest bill (-1.1x): interest is paid from cash or new debt.
- The gross margin fell by 8 points, to 78.7%: costs are rising faster than prices.
- Operating cash flow is negative while the company reports a profit: the profit does not arrive as cash.
- Earnings per share fell 5.5% a year over the last 3 years.
- The company is losing money: the net margin is -36.4%.
- Free cash flow is negative (-61.3% of revenue): the business spends more cash than it brings in.
- The price swings a lot: 61.9% annual volatility. Expect large ups and downs.
- The stock has fallen as much as 82% from a peak. Would you have held through that?
- Return on capital (ROCE) is zero or negative: the business does not earn on the money put into it.
- Pay in shares equals 0% of free cash flow: it dilutes shareholders.
Warning signs
- Recovering from its deepest fall took about 2.3 years.
Strengths
- Debt is low: 0.59x equity.
- The net margin rose by 440 points over 5 years, to -36.4%.
- Analysts expect earnings per share to grow about 31.7% a year over the next years.
- Analysts expect revenue to grow about 57.7% a year over the next years.
- Analysts expect the net margin to improve by 55.6 points from today's -36.4%.
- Revenue grew 52.6% a year over the last 3 years.
Similar companies
MRNA · REGN · 1548.HK · CSL.AX · ARGX · UCB.BR
Questions
What grade does Akeso, Inc. (9926.HK) have?
In our weekly check, Akeso, Inc. is graded D (A to F). Of 22 checks on debt, profit, cash flow and trend: 11 pass, warnings: 1, red flags: 10. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of 9926.HK stock?
This week's biggest flags for Akeso, Inc.: Weak interest cover, Gross margin falling, Profits not backed by cash. In total 11 of 22 checks show a warning or a red flag.
What does Akeso, Inc. do?
Akeso, Inc. is a Healthcare company (Biotechnology) based in China, listed on HKSE as 9926.HK.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-10-24
Open the full analysis